LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 3.33 | uM | LJP6 | 2 | K14 | 72 | hr | 1476 | 1615 | 3694 | 0.4372 | 0.0624 |
| SK-BR-3 | NVP-TAE684 | 3.33 | uM | LJP6 | 3 | K14 | 72 | hr | 1476 | 1493 | 3694 | 0.4042 | 0.0073 |
| SK-BR-3 | Palbociclib | 3.33 | uM | LJP6 | 1 | E14 | 72 | hr | 1476 | 2767 | 3694 | 0.7490 | 0.5819 |
| SK-BR-3 | Palbociclib | 3.33 | uM | LJP6 | 2 | E14 | 72 | hr | 1476 | 2657 | 3694 | 0.7193 | 0.5323 |
| SK-BR-3 | Palbociclib | 3.33 | uM | LJP6 | 3 | E14 | 72 | hr | 1476 | 2873 | 3694 | 0.7777 | 0.6297 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP5 | 1 | C02 | 72 | hr | 1476 | 2092 | 3694 | 0.5663 | 0.2775 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP5 | 2 | C02 | 72 | hr | 1476 | 2482 | 3694 | 0.6719 | 0.4534 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP5 | 3 | C02 | 72 | hr | 1476 | 2726 | 3694 | 0.7379 | 0.5634 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP6 | 1 | E02 | 72 | hr | 1476 | 2146 | 3694 | 0.5809 | 0.3018 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP6 | 2 | E02 | 72 | hr | 1476 | 2547 | 3694 | 0.6895 | 0.4827 |
| SK-BR-3 | PD0325901 | 3.33 | uM | LJP6 | 3 | E02 | 72 | hr | 1476 | 2362 | 3694 | 0.6394 | 0.3993 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 1476 | 4212 | 3694 | 1.1402 | 1.2336 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 1476 | 4284 | 3694 | 1.1597 | 1.2661 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 1476 | 4164 | 3694 | 1.1272 | 1.2119 |
| SK-BR-3 | PD184352 | 3.33 | uM | LJP5 | 1 | L08 | 72 | hr | 1476 | 3481 | 3694 | 0.9423 | 0.9039 |
| SK-BR-3 | PD184352 | 3.33 | uM | LJP5 | 2 | L08 | 72 | hr | 1476 | 3615 | 3694 | 0.9786 | 0.9644 |
| SK-BR-3 | PD184352 | 3.33 | uM | LJP5 | 3 | L08 | 72 | hr | 1476 | 3696 | 3694 | 1.0005 | 1.0009 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 1476 | 1509 | 3694 | 0.4085 | 0.0146 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 1476 | 1659 | 3694 | 0.4491 | 0.0822 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 1476 | 1734 | 3694 | 0.4694 | 0.1160 |
| SK-BR-3 | PF431396 | 3.33 | uM | LJP5 | 1 | E08 | 72 | hr | 1476 | 1467 | 3694 | 0.3971 | -0.0044 |
| SK-BR-3 | PF431396 | 3.33 | uM | LJP5 | 2 | E08 | 72 | hr | 1476 | 1414 | 3694 | 0.3828 | -0.0283 |
| SK-BR-3 | PF431396 | 3.33 | uM | LJP5 | 3 | E08 | 72 | hr | 1476 | 1419 | 3694 | 0.3841 | -0.0260 |
| SK-BR-3 | PF477736 | 3.33 | uM | LJP5 | 1 | J20 | 72 | hr | 1476 | 1418 | 3694 | 0.3839 | -0.0265 |
| SK-BR-3 | PF477736 | 3.33 | uM | LJP5 | 2 | J20 | 72 | hr | 1476 | 1266 | 3694 | 0.3427 | -0.0950 |